Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 6/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11243013 | 0.82 | CYP19A1 (0.51) | CYP19A1HSP90AA1KDM4EKMT2ALMNA | |
| SCHEMBL9729237 | 0.82 | CYP19A1 (0.51) | CYP19A1HSP90AA1KDM4EKMT2ALMNA | |
| SCHEMBL2917482 | 0.71 | CYP19A1 (1.00) | CYP19A1HSP90AA1LMNAMAPTTP53 | |
| SCHEMBL6003706 | 0.70 | ALDH1A1 (0.57) | CYP19A1HSP90AA1KDM4EALDH1A1TSHR | |
| SCHEMBL11036061 | 0.70 | CYP19A1 (0.47) | CYP19A1HSP90AA1KDM4EALDH1A1TSHR | |
| SCHEMBL11036059 | 0.70 | CYP19A1 (0.47) | CYP19A1HSP90AA1KDM4EALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL9382670 | 0.69 | CYP19A1 (0.96) | CYP19A1HSP90AA1LMNAMAPTTP53 | |
| SCHEMBL10940638 | 0.69 | CYP19A1 (0.53) | CYP19A1HSP90AA1KDM4EALDH1A1KMT2A | |
| SCHEMBL6953913 | 0.68 | POLB (0.48) | CYP19A1KDM4EALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL6953906 | 0.68 | POLB (0.48) | CYP19A1KDM4EALDH1A1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050014730-A1 | Anti-fungal formulation of triterpene and essential oil | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2005-01-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014730-A1 | Anti-fungal formulation of triterpene and essential oil | BET1, VRK1, VRK2 | CYP19A1 373/4885HSP90AA1 3246/4885KDM4E 1557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.